Skip to main content

Table 2 Mean relative telomere length by characteristics of women, the Singapore Chinese Health Study

From: Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study

Variables

Age at blood draw

Number

Telomere length (95% CI)

P 1

Age at sample collection, years

 45 to < 55

52.5

2452

1.11 (1.10, 1.12)

< 0.0001

 55 to < 60

56.8

3528

1.09 (1.08, 1.09)

 60 to < 65

62.0

3173

1.04 (1.03, 1.05)

 ≥ 65

70.9

5152

0.98 (0.97, 0.99)

Body mass index, kg/m2

 < 18.5

63.6

1016

1.04 (1.02, 1.05)

0.21

 18.5 to < 23.0

61.8

5859

1.05 (1.04, 1.05)

 23.0 to < 27.5

62.6

5716

1.05 (1.04, 1.05)

 ≥ 27.5

62.3

1714

1.04 (1.03, 1.05)

Level of education

 No formal education

66.4

4580

1.05 (1.04, 1.06)

0.16

 Primary school

61.6

6034

1.04 (1.04, 1.05)

 Secondary school and above

58.3

3691

1.04 (1.03, 1.05)

Dialect group

 Cantonese

62.5

7519

1.04 (1.04, 1.05)

0.08

 Hokkien

62.0

6786

1.05 (1.04, 1.05)

Alcohol consumption, drinks/week

 None

62.5

12,788

1.04 (1.04, 1.05)

0.41

 < 7

60.6

1331

1.05 (1.04, 1.06)

 ≥ 7

62.0

186

1.06 (1.03, 1.09)

Physical activity (weekly)

 No

62.4

10,421

1.04 (1.04, 1.05)

0.71

 Yes

61.9

3884

1.04 (1.04, 1.05)

Smoking status

 Never

61.8

13,053

1.04 (1.04, 1.05)

0.87

 Former

68.3

570

1.04 (1.02, 1.06)

 Current

66.7

682

1.04 (1.03, 1.06)

Age when period became regular

 < 13

59.1

1988

1.04 (1.04, 1.05)

0.77

 13–14

61.5

5152

1.04 (1.04, 1.05)

 15–16

63.5

4578

1.05 (1.04, 1.05)

 ≥ 17

64.7

2087

1.05 (1.04, 1.05)

 Never regular

61.7

500

1.06 (1.04, 1.08)

Age at first live birth

 < 20.0

65.6

2420

1.05 (1.04, 1.06)

0.42

 21.0–25.0

62.5

5357

1.04 (1.04, 1.05)

 26.0–30.0

60.8

3962

1.04 (1.03, 1.05)

 ≥ 31

61.0

1526

1.05 (1.04, 1.06)

 Nulliparous

61.3

1040

1.04 (1.03, 1.06)

Number of live births

 0

61.2

1027

1.04 (1.03, 1.05)

0.07

 1–2

59.3

4327

1.04 (1.03, 1.05)

 3–4

61.3

5748

1.04 (1.04, 1.05)

 ≥ 5

68.6

3158

1.05 (1.05, 1.06)

Menopausal status

 Premenopausal

52.6

955

1.03 (1.02, 1.05)

0.09

 Postmenopausal

63.0

13,350

1.05 (1.04, 1.05)

Age at menopause

 ≤ 49

69.4

2425

1.05 (1.04, 1.06)

0.97

 50–54

68.8

3376

1.04 (1.04, 1.05)

 ≥ 55

57.7

8504

1.04 (1.04, 1.05)

Family history of breast cancer

 No

62.3

14,065

1.04 (1.04, 1.05)

0.20

 Yes

60.6

240

1.06 (1.03, 1.09)

Use of hormone therapy

 Never

63.0

11,890

1.06 (1.05, 1.08)

0.82

 Ever

59.6

1602

1.04 (1.03, 1.05)

 Current

57.4

813

1.04 (1.04, 1.05)

Use of oral contraceptive

 Never

63.2

9888

1.05 (1.04, 1.05)

0.23

 Former/current

60.2

4417

1.04 (1.03, 1.05)

Sleeping hours

 ≤ 6 h

63.2

4871

1.05 (1.04, 1.05)

0.04

 7–8 h

61.8

8503

1.04 (1.04, 1.05)

 ≥ 8 h

62.4

931

1.03 (1.01, 1.04)

  1. 1Values are least-square means (95% confidence intervals), and P values were derived from ANCOVA with adjustment for age at blood collection and dialect group